Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice

Journal: Journal of Clinical Investigation

Published: 2020-03-02

Affiliations: 9

Authors: 20

Institutions	Authors	Share
University Hospital of Lausanne (CHUV), UNIL, Switzerland		0.27
EPFL Swiss Institute for Experimental Cancer Research (ISREC), Switzerland		0.18
Ludwig Center for Cancer Research, UNIL, Switzerland		0.17
EPFL Interfaculty Institute of Bioengineering (IBI), Switzerland		0.10
Roche Pharma Research and Early Development (Roche pRED), Switzerland		0.10
SIB Bioinformatics Core Facility (BCF), Switzerland		0.09
Institute of Molecular Cancer Research (IMCR), UZH, Switzerland		0.05
Center for Vascular and Developmental Biology, NU, United States of America (USA)		0.05

Return

Latest supplement

Nature Index 2020 South Korea

A concerted government push to make South Korea an innovation leader, backed by strong investment and systemic reform, has brought rapid and long-lasting results. The country’s scientific landscape is becoming more diverse and more productive, as a place where upwardly mobile researchers thrive.

Access free